(Q34470332)

2 August 2017

1 reference

title

Stent development and local drug delivery (English)

1 reference

2 August 2017

1 reference

3

Serruys PW

1 reference

2 August 2017

1

Regar E

1 reference

2 August 2017

Sianos G

2

1 reference

2 August 2017

publication date

1 January 2001

1 reference

2 August 2017

published in

British Medical Bulletin

1 reference

2 August 2017

volume

59

1 reference

2 August 2017

page(s)

227-248

1 reference

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Coronary stenting for treatment of ostial stenoses of native coronary arteries or aortocoronary saphenous venous grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Contemporary stent designs: technical considerations, complications, role of intravascular ultrasound, and anticoagulation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Reference chart derived from post-stent-implantation intravascular ultrasound predictors of 6-month expected restenosis on quantitative coronary angiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Does stent design influence restenosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Comparison of mechanical deformation properties of metallic stents with use of stress-strain analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Endovascular stent design dictates experimental restenosis and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

The radioisotope stent for the prevention of restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Current status of radioactive stents for the prevention of in-stent restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Polymeric stenting in the porcine coronary artery model: differential outcome of exogenous fibrin sleeves versus polyurethane-coated stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Clinical trials to prevent restenosis after percutaneous coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Intramural methotrexate therapy for the prevention of neointimal thickening after balloon angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Sustained Local Delivery of Dexamethasone by a Novel Intravascular Eluting Stent to Prevent Restenosis in the Porcine Coronary Injury Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Rapamycin inhibits vascular smooth muscle cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Promotion of microtubule assembly in vitro by taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Novel drug-delivery stent: intravascular ultrasound observations from the first human experience with the QP2-eluting polymer stent system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

Late acute thrombosis after paclitaxel eluting stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2F59.1.227

21 January 2018

Identifiers

DOI

10.1093/BMB/59.1.227

1 reference

2 August 2017

1 reference